Auranofin in rheumatoid arthritis: what variables could affect the clinical response?
Harth
M
M
Rheumatic Diseases Unit, University of Western Ontario, University Hospital, London, Ontario.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D001310:Auranofin / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007107:Immune System / Q000187:drug effects; D066298:In Vitro Techniques; D007408:Intestinal Absorption; D009504:Neutrophils / Q000187:drug effects
D001310:Auranofin